Sun Pharma, Samsung BioLogics ink $55.5 mn pact
As per the pact, Sun Pharma has appointed Samsung BioLogics to manufacture Tildrakizumab.
Jul 04, 2017, 14:34 PM ISTUS FDA accepts application for psoriasis drug: Sun Pharma
Drug major Sun Pharmaceutical Industries on Wednesday said the US health regulator has accepted biologics licence application (BLA) for tildrakizumab for the treatment of psoriasis.
May 24, 2017, 11:49 AM IST